Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study
PaperCitations, authors & open-access status
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 231 citations, 2022 year and hybrid oa status.
231
Citations
2022
Year
hybrid
OA Status